Navigation Links
SCD-iBIO Announces Second International Forum on Commercializing Global Green
Date:8/22/2013

WASHINGTON, Aug. 22, 2013 /PRNewswire-USNewswire/ -- SCD-iBIO, an industrial biotechnology focused group affiliated with the Society of Chemical Manufacturers and Affiliates (SOCMA), today announced that the Second International Forum on Commercializing Global Green: Markets from the Value Chain Perspective will be held November 11-13, 2013, at the Chemical Heritage Foundation (CHF) in Philadelphia, PA.

SCD-iBIO organized the forum to address the broad range of markets industrial biotechnology penetrates and discuss key issues facing the industry, such as shale gas and gas liquids. 

"The advent of shale gas and gas liquids has changed the landscape of chemical production and products," said William B. Armiger, Ph.D., Executive Director of SCD-iBIO and President of BioChemInsights, Inc. "Petroleum feedstocks (specifically naphtha) previously were used, but now natural gas liquids like ethane and propane are taking its place. Because of the feedstock change, industrial biotechnology is being asked to complement natural gas liquid-based production with products that would normally come from naphtha-based steam crackers. Attendees at our meeting will go away with a better understanding of what the future holds for partnerships between shale gas and industrial biotechnology," he said.

The three-day interactive event will include not only in-depth discussions but opportunities to network and form new professional relationships. End markets that will be highlighted include packaging, automotive, advanced biofuels and personal care, as well as intermediate markets for coatings, adhesives and sealants. The forum offers attendees an opportunity to ask questions, express opinions and widen their perspectives.

"Our forums bring together companies along the entire iBIO value chain from raw materials to commercial brands in an intimate and interactive environment where they can gain an in-depth understanding of the market forces and technological advances driving business growth," Armiger said.

About SCD-iBIO

SCD-iBO, an affiliate of SOCMA, is a company member organization that advances the commercial development of industrial biotechnology, which is the application of biology for the environmentally friendly and economically sustainable production and processing of chemicals, plastics, materials and energy. SCD-iBIO provides its members access to the latest technical knowledge in industrial biotechnology combined with the best business practices for commercial development. With industrial biotechnology rapidly emerging as a key technology for economic growth on a global-scale, SCD-iBIO supports its members' common goal of creating a sustainable chemical industry meeting the needs of the 21st century. www.SCD-iBIO.org

Contact:
Jenny Gaines
Manager, Public Relations & Media
(202) 721-4123
gainesj@socma.com


'/>"/>
SOURCE Society of Chemical Manufacturers and Affiliates
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. SOCMA Announces Launch of SCD-iBIO Group
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
6. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
7. WuXi PharmaTech Announces Third-Quarter 2011 Results
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Spherix Announces Third Quarter Financial Results
10. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):